Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Agilent Technologies (A)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 21,169,976
  • Shares Outstanding, K 321,830
  • Annual Sales, $ 4,202 M
  • Annual Income, $ 462,000 K
  • 36-Month Beta 1.30
  • Price/Sales 5.05
  • Price/Cash Flow 23.84
  • Price/Book 4.59

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.35 +5.50%
on 08/24/17
66.45 -1.01%
on 09/19/17
+2.82 (+4.48%)
since 08/22/17
3-Month
58.22 +12.99%
on 08/10/17
66.45 -1.01%
on 09/19/17
+5.17 (+8.53%)
since 06/22/17
52-Week
42.92 +53.26%
on 12/01/16
66.45 -1.01%
on 09/19/17
+19.11 (+40.95%)
since 09/22/16

Most Recent Stories

More News
CORRECTING and REPLACING Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer

Third paragraph of release should read: The expanded approvals for PD-L1 IHC 22C3 pharmDx and KEYTRUDA means that these patients now have the possibility of receiving a targeted anti-PD-1...

A : 65.78 (-0.21%)
Agilent Technologies Announces Cash Dividend of 13.2 Cents per Share

Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 13.2 cents per share of common stock will be paid on October 25, 2017, to all shareholders of record...

A : 65.78 (-0.21%)
Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery

Agilent Technologies Inc. (NYSE: A) has announced a platinum sponsorship agreement with LabCentral, a biotech innovation hub based in Cambridge, Massachusetts. LabCentral is...

A : 65.78 (-0.21%)
Agilent Announces Expanded Use of Cancer Diagnostic in the United States

Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of...

A : 65.78 (-0.21%)
Medical Research Stock Performance Review -- Agilent Technologies, Alere, Quintiles IMS, and Thermo Fisher Scientific

If you want a Stock Review on A, ALR, Q, or TMO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. As access to health care expands around the world,...

A : 65.78 (-0.21%)
Q : 94.70 (+0.51%)
ALR : 50.35 (unch)
TMO : 188.30 (+0.21%)
Agilent Technologies (A) Up 10.6% Since Earnings Report: Can It Continue?

Agilent Technologies (A) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

A : 65.78 (-0.21%)
How Agilent Technologies (A) Stock Stands Out in a Strong Industry

Agilent Technologies (A) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

A : 65.78 (-0.21%)
Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

Agilent Technologies Inc. (NYSE: A) has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first comparative...

A : 65.78 (-0.21%)
Agilent Receives 2017 Scientists' Choice Award for Best New Clinical Laboratory Product

Agilent Technologies Inc. (NYSE: A) has received a 2017 Scientists' Choice Award for Best New Clinical Laboratory Product: the IQFISH Panel for Lung Cancer. The IQFISH panel...

A : 65.78 (-0.21%)
Global Biochip Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Abbott, Agilent Technologies, Illumina, PerkinElmer & Thermo Fisher Scientific

The "Global Biochip Market 2017-2021" report has been added to Research and Markets' offering.

A : 65.78 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Agilent Technologies is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. Agilent has two primary business segments: Bio-Analytical Measurement and Electronic Measurement.

See More

Support & Resistance

2nd Resistance Point 66.48
1st Resistance Point 66.13
Last Price 65.78
1st Support Level 65.57
2nd Support Level 65.36

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.